Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Study - A Randomized, Multi-Center, Double-Blind, Placebo-Controlled Duration Finding Study Evaluating the Efficacy and Safety of Two Week and Four Week Once Daily Treatment of Luliconazole Cream 1% in Patients With Tinea Pedis

NCT00869336 is registered in ClinicalTrials.gov with Tinea Pharmaceuticals as lead sponsor.

NCT NCT00869336
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00869336 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Study - A Randomized, Multi-Center, Double-Blind, Placebo-Controlled Duration Finding Study Evaluating the Efficacy and Safety of Two Week and Four Week Once Daily Treatment of Luliconazole Cream 1% in Patients With Tinea Pedis
Lead sponsor
Tinea Pharmaceuticals
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2009
Completion date
September 30, 2009
Enrollment
147 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

tinea pedis